## Abstract The effects of a short course of a COXβ2 inhibitor on bone healing when the drug is discontinued are unknown. We examined the effects of rofecoxib on bone ingrowth over a 6βweek period using a wellβdefined animal model. The Bone Harvest Chamber was implanted bilaterally in mature rabbit
COX-2 selective NSAID decreases bone ingrowth in vivo
β Scribed by Stuart Goodman; Ting Ma; Michael Trindade; Takashi Ikenoue; Ippe Matsuura; Neal Wong; Nora Fox; Mark Genovese; Don Regula; R.Lane Smith
- Book ID
- 108457030
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 834 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0736-0266
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Excessive polyethylene wear particles from joint replacements may lead to periprosthetic osteolysis and loosening. Nonsteroidal antiβinflammatory drugs (NSAIDs) decrease fracture healing and bone ingrowth. We hypothesized that continuous local infusion of OPβ1 (BMPβ7) would increase loc
## Abstract Nonsteroidal antiinflammatory drugs (NSAIDs) can prevent colorectal tumorigenesis in humans and in rodents. __In vitro__ and __in vivo__ studies indicate that one of their principal antineoplastic avenues is the induction of apoptosis. We have shown previously that NSβ398, which selecti
In vivo, indomethacin blockade of bone formation has been used to illustrate the role of prostaglandins. Indomethacin blocks the constitutive (COX-1) and inducible (COX-2) forms of cyclo-oxygenase, and is therefore nonspecific in its action. To test the hypothesis that COX-2 mediates the bone format